1. Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

2. Levels of the Individual Risk Factors According to Presence or Absence of MetS a Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

3. Total Mortality According to Presence or Absence of the Metabolic Syndrome Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

4. Risk of Mortality According to Individual MetS Criteria Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

5. Relative risk of death according to individual metabolic syndrome criteria among 4258 older adults D. Mozaffarian et al. Arch Intern Med. 2008;168:969-978 Each criterion is evaluated in sex-specific quintiles adjusted for age, each of the other metabolic syndrome criteria, and other demographic and lifestyle risk factors as detailed in Table 3, footnote a. For evaluation of blood pressure and fasting glucose levels, individuals treated with medications for hypertension (n=1711) or diabetes (n=305) are included in separate categories (Meds). Shaded diamonds represent relative risks; vertical lines extending from the diamonds represent 95% confidence intervals. HDL indicates high-density lipoprotein.

6. Risk of Mortality According to Individual MetS Criteria Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

7. Mortality rates according to different combinations of presence or absence of elevated fasting glucose level (EFG), hypertension (HTN), and metabolic syndrome (MetS), adjusted for age, sex, and other demographic and lifestyle risk factors Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978

8. Relative risk of cardiovascular disease (CVD) mortality and non-CVD mortality according to presence or absence of the metabolic syndrome (MetS) overall and with or without elevated fasting glucose levels (EFG) and hypertension (HTN) (A) and according to presence or absence of EFG and HTN alone (B) Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:969-978